This article walks through three things in order: the no-human-data reality and what preclinical work does and doesn't establish, the theoretical oncological concern tied to the HGF/c-Met pathway, and the anecdotal adverse effects community sources describe
The name alone does not guarantee quality, legal status, sterility, dose accuracy, or safety
solanacearum employs a sophisticated virulence strategy through its type III secretion effector RipAY
Loss of appetite Fatigue Headache Dry, itchy skin Nausea Unexplained weight loss Changes in mental status or mood Numbness, particularly in the hands or feet Vomiting High blood pressure (hypertension) Seizures Shortness of breath Pain between the ribs and hips Swelling in the legs, ankles, and feet Too much or too little urination Bloody stools Bruising and bleeding easily Consult your primary care provider if you experience any of these symptoms, Kalolwala says